MET vs UNH
Metlife Inc. and Unitedhealth Group Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | MET | UNH |
|---|---|---|
| Revenue | $77.1B | $447.6B |
| Net income | $3.4B | $12.1B |
| Gross margin | — | 88.7% |
| Net margin | 4.4% | 2.9% |
| Return on equity | 12.1% | 12.2% |
| Diluted EPS | $4.71 | $13.23 |
| Dividend / share | $2.25 | $8.73 |
| Payout ratio | 44.7% | 65.7% |
| Free cash flow | — | $16.1B |
| Equity | $28.4B | — |
| Net debt / equity | −0.25× | 0.54× |
| Current ratio | — | 0.79× |
| Revenue CAGR 5y | 2.6% | 11.7% |
| Profit CAGR 5y | −9.0% | −4.8% |
UNH bills 5.8× the revenue of MET, and MET keeps more of each dollar of revenue as profit (4.4% against 2.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | MET | UNH |
|---|---|---|
| FY2025 | $77.1B | $447.6B |
| FY2024 | $71.0B | $400.3B |
| FY2023 | $66.9B | $371.6B |
| FY2022 | $68.8B | $324.2B |
| FY2021 | $68.7B | $287.6B |
| FY2020 | $67.8B | $257.1B |
| FY2019 | $69.6B | $242.2B |
| FY2018 | $67.9B | $226.2B |
| FY2017 | $62.3B | $201.2B |
| FY2016 | $60.8B | $184.8B |
Net income by year
Bottom line
| Fiscal year | MET | UNH |
|---|---|---|
| FY2025 | $3.4B | $12.1B |
| FY2024 | $4.4B | $14.4B |
| FY2023 | $1.6B | $22.4B |
| FY2022 | $5.3B | $20.1B |
| FY2021 | $6.9B | $17.3B |
| FY2020 | $5.4B | $15.4B |
| FY2019 | $5.9B | $13.8B |
| FY2018 | $5.1B | $12.0B |
| FY2017 | $4.0B | $10.6B |
| FY2016 | $850.0M | $7.0B |